240 related articles for article (PubMed ID: 35685476)
1. Targeting LIF/LIFR signaling in cancer.
Viswanadhapalli S; Dileep KV; Zhang KYJ; Nair HB; Vadlamudi RK
Genes Dis; 2022 Jul; 9(4):973-980. PubMed ID: 35685476
[TBL] [Abstract][Full Text] [Related]
2. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.
Viswanadhapalli S; Luo Y; Sareddy GR; Santhamma B; Zhou M; Li M; Ma S; Sonavane R; Pratap UP; Altwegg KA; Li X; Chang A; Chávez-Riveros A; Dileep KV; Zhang KYJ; Pan X; Murali R; Bajda M; Raj GV; Brenner AJ; Manthati V; Rao MK; Tekmal RR; Nair HB; Nickisch KJ; Vadlamudi RK
Mol Cancer Ther; 2019 Aug; 18(8):1341-1354. PubMed ID: 31142661
[TBL] [Abstract][Full Text] [Related]
3. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract][Full Text] [Related]
4. LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer.
Tang W; Ramasamy K; Pillai SMA; Santhamma B; Konda S; Pitta Venkata P; Blankenship L; Liu J; Liu Z; Altwegg KA; Ebrahimi B; Pratap UP; Li X; Valente PT; Kost E; Sareddy GR; Vadlamudi RK; Nair HB; Tekmal RR; Viswanadhapalli S
Cell Death Discov; 2021 Aug; 7(1):216. PubMed ID: 34400617
[TBL] [Abstract][Full Text] [Related]
5. The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights.
Halder S; Parte S; Kshirsagar P; Muniyan S; Nair HB; Batra SK; Seshacharyulu P
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188737. PubMed ID: 35680099
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.
Ebrahimi B; Viswanadhapalli S; Pratap UP; Rahul G; Yang X; Pitta Venkata P; Drel V; Santhamma B; Konda S; Li X; Sanchez ALR; Yan H; Sareddy GR; Xu Z; Singh BB; Valente PT; Chen Y; Lai Z; Rao M; Kost ER; Curiel T; Tekmal RR; Nair HB; Vadlamudi RK
NPJ Precis Oncol; 2024 May; 8(1):118. PubMed ID: 38789520
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor signaling in Xenopus embryo: Insights from gain of function analysis and dominant negative mutant of the receptor.
Jalvy S; Veschambre P; Fédou S; Rezvani HR; Thézé N; Thiébaud P
Dev Biol; 2019 Mar; 447(2):200-213. PubMed ID: 30578761
[TBL] [Abstract][Full Text] [Related]
8. Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.
Zhang W; Shi X; Chen R; Zhu Y; Peng S; Chang Y; Nian X; Xiao G; Fang Z; Li Y; Cao Z; Zhao L; Liu G; Sun Y; Ren S
Mol Ther; 2020 Nov; 28(11):2473-2487. PubMed ID: 32592689
[TBL] [Abstract][Full Text] [Related]
9. Regulation of neurokine receptor signaling and trafficking.
Nathanson NM
Neurochem Int; 2012 Nov; 61(6):874-8. PubMed ID: 22306348
[TBL] [Abstract][Full Text] [Related]
10. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.
Omokehinde T; Jotte A; Johnson RW
J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
[TBL] [Abstract][Full Text] [Related]
11. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer.
Liu YN; Chen WY; Liu MK; Yeh HL; Chen WH; Jiang KC; Li HR; Chen ZQ; Wang WH; Abou-Kheir W; Wen YC
Mol Oncol; 2024 Jun; 18(6):1665-1686. PubMed ID: 38381121
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth.
Blankenship L; Pratap UP; Yang X; Liu Z; Altwegg KA; Santhamma B; Ramasamy K; Konda S; Chen Y; Lai Z; Zheng S; Sareddy GR; Valente PT; Kost ER; Nair HB; Tekmal RR; Vadlamudi RK; Viswanadhapalli S
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358818
[TBL] [Abstract][Full Text] [Related]
15. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Di Giorgio C; Lupia A; Marchianò S; Bordoni M; Bellini R; Massa C; Urbani G; Roselli R; Moraca F; Sepe V; Catalanotti B; Morretta E; Monti MC; Biagioli M; Distrutti E; Zampella A; Fiorucci S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359879
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
Di Giorgio C; Marchianò S; Marino E; Biagioli M; Roselli R; Bordoni M; Bellini R; Urbani G; Zampella A; Distrutti E; Donini A; Graziosi L; Fiorucci S
Front Oncol; 2022; 12():939969. PubMed ID: 35847866
[TBL] [Abstract][Full Text] [Related]
17. Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex.
Port MD; Gibson RM; Nathanson NM
J Neurochem; 2007 May; 101(3):782-93. PubMed ID: 17448148
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
Schiemann WP; Graves LM; Baumann H; Morella KK; Gearing DP; Nielsen MD; Krebs EG; Nathanson NM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5361-5. PubMed ID: 7777512
[TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
[TBL] [Abstract][Full Text] [Related]
20. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.
Di Giorgio C; Bellini R; Lupia A; Massa C; Bordoni M; Marchianò S; Rosselli R; Sepe V; Rapacciuolo P; Moraca F; Morretta E; Ricci P; Urbani G; Monti MC; Biagioli M; Distrutti E; Catalanotti B; Zampella A; Fiorucci S
Front Oncol; 2023; 13():1140730. PubMed ID: 36998446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
